DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 1.50% to $11.13 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.57% to 26,541.35 and the Dow Jones Industrial Average rising 0.20% to 53,569.44.
This was the stock's second consecutive day of losses.
Corbus Pharmaceuticals Holdings Inc. closed 45.87% short of its 52-week high of $20.56, which the company achieved on October 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 1.68% to $5.44, Fortress Biotech Inc. (FBIO) fell 0.36% to $2.80, and Viking Therapeutics Inc. (VKTX) fell 1.51% to $33.86.
Data source: Dow Jones Market Data, FactSet. Data compiled August 27, 2026.